Bohai Pharmaceuticals Group, Inc. (BOPH 1.50, 0.00, 0.00%) , a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine in China, today announces the availability of a new online Investor Fact Sheet.
"As part of our goal in keeping investors informed with the latest developments at Bohai, we are releasing our new fact sheet, which we plan to update regularly," said Mr. Hongwei Qu, President and Chief Executive Officer of Bohai Pharmaceuticals Group. "Bohai is able to take advantage of the increasing demand for Traditional Chinese Medicine through our focused corporate growth strategy, which emphasizes quality ingredients and proactive sales and marketing efforts as we leverage the protected manufacturing status and national insurance coverage for certain of our pharmaceutical products."
Mr. Qu continued, "We believe Bohai Pharmaceuticals is a strategically well positioned TCM manufacturer with long term growth potential, and we look forward to providing our investors with updates on our progress over the coming weeks and months."
The Investor Fact Sheet provides a concise overview of Bohai Pharmaceuticals' business model and the company's various opportunities in China's healthcare market, and will prove an important resource for existing shareholders and prospective investors alike.
No comments:
Post a Comment